Tobacco alternatives Torigians Story

A Leaf of Faith: Puzant Torigian and the Quest for a Tobacco Alternative

Driven by a desire to help people quit smoking, Puzant Torigian invested his life savings – and risked his health – in a novel venture. In 1997, amidst growing public backlash against Big Tobacco, Torigian, an entrepreneur based in Hackensack, New Jersey, introduced "Bravo" cigarettes. His factory, established near Atlanta's airport, attracted significant media attention, receiving unexpectedly positive coverage. Torigian operated outside the established tobacco industry. Bravo cigarettes contained only lettuce, treated to resemble tobacco. The lettuce was formed into sheets, finely cut, infused with botanicals, and packaged like conventional cigarettes. Torigian marketed Bravo as mimicking the flavour profile of a cigarette without the harmful nicotine and tar. He stressed, however, that his four decades of development aimed at more than just a safer substitute. He envisioned Bravo as a smoking cessation aid.

Bravo: A Sensory Substitute for Nicotine Cravings

Bravo's former website described the product as fulfilling the sensory and psychological aspects of traditional cigarettes, from the unpacking and lighting to the inhaling. When users wanted to quit nicotine but experienced cravings, they could use Bravo as a replacement until they no longer needed either. The website assured consumers that Bravo facilitated complete cessation from nicotine dependence safely, naturally, and gradually. This claim seemed unusual at the time. Yet Bravo represented just one iteration in a century-long search for tobacco cigarette alternatives. Torigian's dedication to Bravo, its limited success, and its eventual decline illustrate the rapid post-1950s shift in understanding smoking's risks and optimal cessation methods. Louis M. Kyriakoudes, an expert on nicotine addiction studies and the tobacco trade at the Albert Gore Research Center, notes that tobacco has always had its detractors.

Early Attempts at Tobacco Alternatives

Some early European adopters in the 17th century criticised tobacco's smell, taste, and oral effects. Concerns about price and availability also arose, alongside anxieties about its health consequences. Many, therefore, sought alternative smokables that would replicate the sensory experience. By the mid-1800s, American innovators patented tobacco substitutes using inexpensive, often aromatic materials like shredded corn stalks or rhubarb and sunflower leaves. A few of these botanical cigarettes achieved modest success towards the end of the 19th century. Their intended use, however, was primarily therapeutic, to treat respiratory ailments like nasal congestion. The most notable outcome of these milder, non-tobacco products was menthol-infused cigarettes, perceived as gentler on the throat and airways. The search for an effective tobacco replacement intensified in the late 1940s. This coincided with research clearly linking tobacco consumption to lung cancer.

Image Credit - Atlas Obscura

The Rise of Health Concerns and Tobacco Industry Response

Initially, researchers like Jean U. Koree, whose expertise ranged from aircraft parts to injectable medications, pioneered this safety-focused movement. In 1948, he secured a patent to process tree pulp as a pseudo-tobacco product. As Kyriakoudes describes, subsequent studies generated public alarm between 1953 and 1954. This led major tobacco companies to explore these alternative products. Simultaneously, they launched campaigns downplaying tobacco's risks and disputing the research. Kyriakoudes observes that the focus was more on reputation and public perception than public health. The tobacco companies felt obligated to offer consumers a supposedly lower-risk product. Torigian began researching such alternatives in 1959. He was born in 1922 in Constantinople before immigrating with his family to America in 1929. They eventually established a pharmaceutical manufacturing lab in New York.

Torigian's Early Career and the Genesis of Bravo

A former navy pharmacist during wartime, Torigian earned a pharmacy degree from Columbia University in 1949. He then began a career with small pharmaceutical companies in New York City. Later accounts from Torigian’s career suggest a mentor, Joseph Genovese, who managed a retail pharmacy, encouraged Torigian to develop lower-risk tobacco products. Torigian described replacing nicotine in tobacco as surprisingly simple, fast, and effective. Initially, like others exploring herbal alternatives, Torigian envisioned people simply swapping one habit for a potentially beneficial one.

However, accounts from his family indicate Torigian worried that herbal alternatives might pose health risks through smoke and particulate matter. Torigian, therefore, shifted his focus to marketing a tobacco-free product aimed at consumers wanting to gradually reduce their nicotine intake. Torigian passed away in late 2021, near his 100th birthday. Accounts from his wife, Joanne Torigian, offer insight into his Bravo project. She is credited with naming the product. Joanne's recollections reveal that "Bravo" was chosen based on her positive feedback to Puzant, reflecting her Italian heritage.

From Pharmacy to Lettuce: Torigian's Unconventional Research

During his lifetime, Torigian launched several medical ventures. These included developing an injectable blood thinner and a treatment for childhood physical discomfort. However, those close to him emphasized his commitment to helping nicotine-dependent populations. In 1960, records show approval of Torigian's proprietary process for transforming leafy herbs. This included preparation, curing, and packaging techniques. Early accounts suggest Torigian believed lettuce could visually and flavourfully mimic nicotine. He reasoned it produced minimal biologically harmful waste. Still, he tested over two hundred different herbs in pursuit of scientific validation. These tests included plants like carrot, peanut, and watermelon tops, hickory, grape, and cabbage leaves, as well as various maple and rhododendron species. His process involved personally gathering ingredients and smoking them for research purposes. Post-mortem reports revealed negative results from these tests. By 1965, he returned his focus to lettuce.

Image Credit - Atlas Obscura

Production Challenges and Early Marketing Efforts

Many speculated about his reasoning. His actions, however, focused on securing financial backing and establishing a production facility in Hereford, Texas. Employing approximately two hundred people, the factory achieved a production rate of around 90,000 packs per month. While he admittedly overestimated projections, evidence suggests Torigian held reasonable expectations for market acceptance. He noted the lack of tools for people to quit smoking. Internal perspectives highlighted the significant consumer demand for supposedly healthier tobacco products.

Illustrating Torigian's conviction in his solution to smoking's harms, posthumous accounts reveal his congressional testimony. He urged Congress to reject proposals for cigarette filters. His communication also included scathing critiques of nicotine and the tobacco industry. By late 1969, Bravo defaulted on payment obligations. The company closed within two years. Kyriakoudes suggests several reasons for these challenges, including marketing difficulties. Competing against a heavily funded industry promoting supposed safety and facing internal operational and partnership issues likely contributed to the problems.

Taste Troubles and the Decline of Herbal Alternatives

Accounts from former colleagues, however, indicate Torigian's product suffered from quality issues. The flavour reportedly bore little resemblance to its nicotine-rich counterpart. Reviewers described the taste as similar to crushed breakfast cereal and used pantyhose. Others attempting similar herbal cigarette alternatives also encountered negative feedback regarding smell, texture, and overall sensory experience. They experimented with various herbs like banana and taro, along with flavour additives like saffron and cumin. However, major industries seemingly abandoned their pursuit of tobacco alternatives by the mid-1970s.

Kyriakoudes presents evidence that, by this time, these organizations employed strategies to obfuscate research and interfere with legislative processes. Tobacco industry insiders also possessed intimate knowledge of nicotine's addictive properties and its ability to retain customers. Many believe the continued personal initiatives of some herbal cigarette developers were driven by genuine desires to reduce health risks and offer cessation strategies. This aligns with Torigian's approach of experimenting with various herbs. After the loss of his family's business, evidence suggests he persisted, still believing in his approach.

Torigian's Later Years and Renewed Hope for Bravo

He relocated to Malaysia to pursue a career in pharmaceutical manufacturing. Later, he managed and improved his family's production line. Around 1984, he officially retired. However, records show he continued providing consulting services to nutrition and biomedical startups. Separately, Torigian family archives indicate he spent much of his free time experimenting with improvements to his original creation. He also explored novel chemical applications for medical solutions. He still believed a revised version of Bravo could succeed. His motivation stemmed partly from passion but also from a perceived unmet need for services like Bravo. The negative health consequences of cigarettes gradually entered public discourse, despite challenges posed by tobacco companies. However, government support for smoking cessation aids, like nicotine gum, only emerged in the mid-1980s.

Changing Perceptions of Nicotine Addiction and the Re-emergence of Bravo

Towards the end of the 1980s, a scientific consensus emerged favouring nicotine replacement therapy and counselling as the most effective cessation methods. Torigian joined researchers who recognized potential gaps in available resources. He advocated for supplementing, rather than substituting, existing nicotine therapies. His timing also coincided with a growing acceptance that smoking wasn't solely a biological compulsion. Even with evidence that nicotine functioned like addictive drugs, many medical professionals hesitated to label large portions of the population as needing treatment for a common, albeit undesirable, physical craving. Torigian, however, maintained that nicotine addiction could be addressed through combined therapies and psychological strategies. Bravo reportedly helped Torigian overcome his own nicotine addiction. Joanne confirms they both smoked regularly until Bravo's development (Torigian preferred menthol).

Torigian arranged a hospital visit for Joanne. This visit showed her images of lung damage in long-term smokers. The experience inspired Joanne to quit immediately. Torigian, however, followed a personal program of gradual reduction aided by his own creation. He believed this approach alleviated his strongest tobacco cravings. Torigian reintroduced Bravo in the late 1990s, amidst a burgeoning but unsettled smoking cessation market. This followed academic and medical tests supporting the low-risk assessment of leafy herbs and their potential to reduce nicotine cravings.

Image Credit - Atlas Obscura

Marketing Bravo in a Changing Landscape

Doctors joined his efforts, asserting the efficacy of herbs in combating nicotine addiction. Instructions for herbal cigarettes, promising substantial sales, appeared frequently. Bravo's marketing materials from this period also addressed taste concerns. Statements like, "You are encouraged to try several packs to allow your palate to adjust to our unique offering," and "Savor the distinct taste and superior aroma," became common. Wallace Pickworth, a renowned researcher in cigarette smoke toxicity, noted his team used Bravo as a placebo in nicotine studies. He expressed interest in herbal nicotine alternatives for craving management. However, taste issues prevented further consideration of Bravo as a reliable placebo.

Bravo became available throughout the US via independent health food stores. However, its primary consumer base viewed it as a novelty item, finding its niche in places like witch covens and Hollywood backlots. Information on Bravo's eventual market decline remains scarce. However, Torigian family documents, collected during scrutiny of his product's medicinal marketing claims, suggest the business naturally ceased operations as nicotine replacement therapies gained wider acceptance among consumers and health professionals.

Torigian's Legacy and the Persistence of Herbal Alternatives

Torigian seemingly maintained his belief in having pioneered a novel approach to helping nicotine addicts. He left behind a legacy in the harm reduction space. A community dedicated to herbal smoking cessation methods persists in certain cultural groups. Research reveals similar efforts to develop healthier cigarette alternatives in the East and Thailand. These projects utilize tea leaves, chicory, lotus, and other botanicals. Global online sales data reveals significant sales of such products, often with unsubstantiated health claims related to nicotine craving reduction. While many health experts question the efficacy and safety of this approach, others, like Joanne, believe Torigian created a product with worthy health intentions. A future for this technology remains a possibility.

The pursuit of less harmful smoking alternatives continues. This pursuit reflects a long-standing desire to replicate the sensory experience of smoking without the associated health risks. From 17th-century skeptics to modern-day innovators, the search for a safer smoke persists. Torigian's story, though ultimately a commercial failure, highlights the dedication and innovation driving this ongoing quest. His commitment to a lettuce-based cigarette, while unconventional, underscores the enduring human desire for healthier alternatives to harmful habits.

The Complexities of Nicotine Addiction and Cessation

Torigian's story also illuminates the complex nature of nicotine addiction. His belief in a combined approach, addressing both the physical and psychological aspects of addiction, resonates with contemporary understanding. While nicotine replacement therapies and counselling remain the gold standard, the search for complementary strategies continues. The allure of a "safe cigarette" remains powerful. This allure drives continued research and development into various alternatives, including e-cigarettes and heat-not-burn products. These products, while potentially less harmful than traditional cigarettes, still pose health risks and raise concerns about their long-term effects. The World Health Organization emphasizes the importance of evidence-based cessation methods. They advocate for comprehensive tobacco control policies, including taxation, public awareness campaigns, and support for quit services. The journey towards a smoke-free world faces numerous challenges. These challenges include the powerful influence of the tobacco industry and the persistent appeal of nicotine.

The Future of Smoking Cessation

However, ongoing research, innovative approaches, and evolving public attitudes offer hope. Torigian's story, though a footnote in the history of tobacco alternatives, serves as a reminder of the enduring human ingenuity in seeking solutions to complex problems. His legacy lies not in commercial success but in his unwavering belief in the possibility of a healthier alternative. This belief continues to inspire the ongoing quest for a truly safe smoke. The search for a safe and effective tobacco alternative has spanned centuries. This search has yielded various approaches, from herbal cigarettes to sophisticated electronic devices.

Each iteration reflects the evolving understanding of nicotine addiction and the desire to minimize smoking-related harm. While a universally accepted "safe cigarette" remains elusive, the ongoing quest holds promise for future innovations. These innovations may one day provide smokers with truly effective and harmless alternatives to traditional cigarettes. The future of smoking cessation likely lies in a multifaceted approach. This approach will combine pharmacological interventions, behavioural therapies, and technological advancements. The goal remains to empower individuals to break free from nicotine's grip and achieve a healthier, smoke-free life.

Image Credit - Atlas Obscura

Beyond Bravo: The Continuing Search for Alternatives

While Torigian's Bravo cigarettes ultimately faded into obscurity, the search for tobacco alternatives continues. Researchers and entrepreneurs explore various avenues, driven by the immense public health burden of smoking. The Centers for Disease Control and Prevention (CDC) reports smoking remains the leading cause of preventable death in the United States. This stark reality fuels the ongoing quest for less harmful alternatives. One prominent area of research focuses on harm reduction. This approach aims to minimize the negative health impacts of smoking by offering less harmful alternatives to traditional cigarettes. E-cigarettes, or vapes, have emerged as a popular alternative. These devices heat a liquid containing nicotine, producing an aerosol that users inhale. While e-cigarettes eliminate the combustion process of traditional cigarettes, thereby reducing exposure to many harmful chemicals, they still deliver nicotine, a highly addictive substance.

E-cigarettes: A Controversial Alternative

The long-term health effects of e-cigarettes remain a subject of ongoing research and debate. Public Health England, for instance, has declared e-cigarettes to be 95% less harmful than traditional cigarettes, however. This claim remains controversial, with other health organizations expressing caution about their long-term safety. Another alternative gaining traction is heat-not-burn tobacco products. These devices heat tobacco to a lower temperature than traditional cigarettes, producing an aerosol containing nicotine and other chemicals. While proponents argue that heat-not-burn products reduce exposure to harmful chemicals compared to conventional cigarettes, their long-term health effects remain unclear. Research into alternative nicotine delivery systems continues to evolve. Scientists explore novel approaches, such as nicotine pouches and lozenges, to provide smokers with less harmful ways to satisfy their nicotine cravings.

The Role of Regulation and Public Health Policy

The proliferation of alternative nicotine products presents significant regulatory challenges. Governments grapple with balancing the potential benefits of harm reduction with the need to protect public health, particularly among young people. The increasing popularity of vaping among teenagers has raised concerns about a new generation becoming addicted to nicotine. Public health officials advocate for comprehensive regulations to address these concerns. These regulations include age restrictions, marketing limitations, and product safety standards. Effective tobacco control policies play a crucial role in reducing smoking rates. These policies encompass a range of measures, from increasing tobacco taxes to implementing smoke-free laws. The World Health Organization's Framework Convention on Tobacco Control provides a comprehensive blueprint for countries to implement effective tobacco control strategies.

The Importance of Cessation Support

While alternative nicotine products may play a role in harm reduction, supporting smokers in quitting altogether remains a paramount public health goal. Evidence-based cessation interventions, such as counselling and nicotine replacement therapy, have proven effective in helping smokers quit. Access to these interventions remains crucial in supporting smokers who wish to quit. Public awareness campaigns play a vital role in educating the public about the dangers of smoking and the benefits of quitting. These campaigns aim to dispel misinformation about alternative nicotine products and promote evidence-based cessation methods. The fight against tobacco remains a global challenge. International collaboration and knowledge sharing are essential in developing and implementing effective tobacco control strategies. The lessons learned from past efforts, including Torigian's unconventional approach with Bravo cigarettes, inform the ongoing search for solutions to the global tobacco epidemic.

Learning from the Past: The Evolution of Cessation Strategies

Torigian's story, while unique, reflects a broader historical trend of seeking less harmful alternatives to tobacco. His focus on mimicking the sensory experience of smoking, albeit with a lettuce-based product, foreshadows the development of modern alternatives like e-cigarettes and heat-not-burn products. The key difference lies in the understanding of nicotine addiction. While Torigian initially aimed to replace nicotine with a potentially beneficial herb, contemporary approaches acknowledge nicotine's powerful addictive properties. Harm reduction strategies now focus on providing nicotine in less harmful ways, while also encouraging complete cessation.

The evolution of smoking cessation strategies reflects advancements in scientific understanding and changes in societal attitudes. Early approaches often relied on willpower and behavioural modifications. The recognition of nicotine addiction as a medical condition led to the development of pharmacological interventions, such as nicotine replacement therapy and medications like bupropion and varenicline. These interventions, combined with counselling and behavioural support, have significantly improved quit rates.

Image Credit - Atlas Obscura

The Role of Technology in Smoking Cessation

Technology plays an increasingly important role in smoking cessation. Mobile apps, wearable devices, and online platforms offer personalized support, tracking tools, and access to resources. These digital tools empower individuals to manage their quit journey and connect with a supportive community. The National Health Service (NHS) offers a range of digital tools to support smokers in their quit attempts. These resources provide practical advice, personalized plans, and access to support networks. Artificial intelligence (AI) also holds promise in the field of smoking cessation. Researchers explore AI-powered chatbots and virtual coaches to provide personalized support and guidance. These technologies offer the potential to reach a wider audience and deliver tailored interventions based on individual needs and preferences.

Addressing Health Disparities in Smoking Cessation

Despite advancements in cessation strategies, significant disparities persist in smoking rates among different populations. Factors such as socioeconomic status, race, and ethnicity influence smoking prevalence and access to cessation resources. Public health efforts must address these disparities to ensure equitable access to effective cessation support. The American Lung Association advocates for policies to reduce tobacco-related health disparities. These policies include targeted interventions for vulnerable populations and increased funding for cessation programs in underserved communities. The tobacco industry's targeted marketing towards specific demographics, including low-income communities and racial and ethnic minorities, contributes to these disparities. Combating these predatory marketing practices remains crucial in achieving health equity in smoking cessation.

The Ongoing Fight Against Tobacco

The fight against tobacco continues on multiple fronts. Advocacy groups work tirelessly to raise awareness about the dangers of smoking and advocate for stronger tobacco control policies. Researchers continue to explore novel approaches to smoking cessation, including vaccines and medications that target nicotine receptors in the brain. International cooperation remains essential in addressing the global tobacco epidemic. The World Health Organization's MPOWER measures provide a framework for countries to implement effective tobacco control strategies. These measures include monitoring tobacco use, protecting people from tobacco smoke, offering help to quit tobacco use, warning about the dangers of tobacco, enforcing bans on tobacco advertising, promotion and sponsorship, and raising taxes on tobacco.

While the pursuit of a "safe cigarette" persists, the ultimate goal remains a smoke-free world. This goal requires a comprehensive approach that combines individual empowerment, policy change, technological innovation, and sustained public health efforts. Puzant Torigian's story, though a commercial failure, serves as a reminder of the enduring human desire for healthier alternatives and the ongoing quest for solutions to complex health challenges. His dedication, while unconventional, echoes the spirit of innovation that drives progress in the fight against tobacco. The legacy of his lettuce-based cigarette lies not in its market success, but in its contribution to the ongoing narrative of seeking a safer smoke.